Canesten Thrush

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Canesten Thrush

This foundational section defines the medicinal identity, composition, and general action of the product, Canesten Thrush, based on its active pharmaceutical ingredient, Clotrimazole.

Property Description
Active ingredient Clotrimazole
Form Vaginal tablet (Pessary) and External cream
Pharmacological class Azole Antifungal / Broad-spectrum
Common use Thrush (Vaginal candidiasis)
Origin Synthetic compound

What Type of Medicine is Canesten Thrush?

Canesten Thrush is an established Over-The-Counter (OTC) antifungal medicine whose primary role is to treat the localized fungal infection known as Thrush (Vaginal candidiasis). The drug is categorized within the Azole antifungal class, characterized as a broad-spectrum agent that is effective against a variety of yeasts and fungi, including Candida albicans, the usual cause of the condition. Clotrimazole is globally recognized for its efficacy against these fungal pathogens, a fact supported by extensive clinical recognition in pharmacological studies. The specific formulation is often positioned as a complete local treatment solution for adult women.

Composition and Physical Forms of the Preparation

The sole Active ingredient in the medicine is Clotrimazole (INN), which is a Synthetic compound and an Imidazole derivative in official chemical classification systems. This core ingredient is presented in distinct Dosage form(s) to ensure effective local treatment. These typically include a Vaginal tablet (pessary) intended for Intravaginal insertion, and an External cream designed for Topical application to the surrounding tissues. The common packaging as a Combination pack (Duo) is a distinctive feature, designed to provide comprehensive local coverage, addressing both the source of the infection and the accompanying external discomfort.

How Does Clotrimazole Achieve Its Purpose?

Clotrimazole achieves its purpose by working directly at the site of the infection to stop the growth of fungi and eliminate them. The active ingredient works by selectively interfering with the structural integrity of the fungal cell membrane, leading to both fungistatic action (halting the pathogen's growth) and fungicidal action (actively killing the fungal cells). This documented dual capacity is essential for resolving the fungal infection by neutralizing the fungal overgrowth that is the source of the condition.

Regulatory References

  1. FDA DailyMed Label
  2. Mechanism of Action (NCBI/NIH)

What side effects are possible with Canesten Thrush?

Possible Side Effects and Safety Information

This section outlines the adverse reactions and safety characteristics of Clotrimazole, the active ingredient in Canesten Thrush, as documented in official government regulatory documents.


Adverse Reaction Scope

The most commonly documented undesirable effects are local reactions, classified by regulators under the Reproductive System and Breast Disorders and General Disorders and Administration Site Conditions categories. These can include vulvovaginal burning sensation, pruritus (itching), pain, and irritation at the application site. Other effects such as oedema (swelling), rash, abdominal pain, and nausea are also documented in regulatory sources.

Less frequently, or classified with Frequency Not Known (based on spontaneous post-marketing reports), are potentially serious systemic reactions linked to the Immune System Disorders. These documented reactions include Hypersensitivity, Angioedema, and Anaphylactic Reactions, which may present with systemic symptoms such as syncope (fainting) or hypotension (low blood pressure).

Regulatory Safety Considerations

The official safety information includes important high-level limitations. The product is contraindicated in individuals with a known hypersensitivity to the active substance or any of its inactive ingredients.

The label also contains specific constraints regarding other products: the formulation may damage latex contraceptives (condoms and diaphragms), which could reduce their effectiveness. Furthermore, concomitant use with the oral immunosuppressants tacrolimus or sirolimus may result in increased plasma levels of these medications.

For specific populations, use during pregnancy should only occur under the supervision of a doctor or midwife. The medicine is also restricted from use in children under 12 years of age, as defined in official regulatory labeling.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Clotrimazole, the active ingredient in Canesten Thrush, establishes that acute systemic intoxication is highly unlikely. This classification is due to the minimal systemic absorption of the drug following the intended vaginal or topical application, which typically prevents the accumulation of significant levels in the bloodstream.

Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations Gastrointestinal disturbances, including nausea and vomiting, or Central Nervous System effects, such as dizziness and vertigo (documented following accidental oral ingestion).
Severity classification Acute toxicity is not anticipated with intended use; the risk profile relates to accidental ingestion.
Emergency-response statement Seek immediate medical attention or contact emergency services immediately in the event of accidental oral ingestion of the vaginal tablet or cream.

Resulting Overdose Structure

Official overdose statements:

  • Accidental oral ingestion is the circumstance documented by regulators to cause potential systemic exposure.
  • If symptomatic, manifestations include specific gastrointestinal distress and CNS disturbances.
  • No specific antidote is known for Clotrimazole overdose.
  • Management of overdose is officially described as symptomatic and supportive.

The regulatory documents structure the overall overdose profile around the minimal systemic risk associated with intended use. Official instructions mandate urgent medical intervention only for accidental oral ingestion, which requires clinical observation and supportive treatment due to the documented absence of a known specific antidote.

Therapeutic Uses of Canesten Thrush

What Canesten Thrush Treats: Main Uses and Benefits

The medication is commonly used to help address the core infection, vulvovaginal candidiasis (commonly known as Thrush). It is generally relevant for managing both typical, acute episodes and recurrent thrush, and is commonly used to address the fungal pathogen. This medicine is also used to treat these infections in adults.

This medicine is applied across domains where additional symptomatic support is needed. It helps address symptom clusters that may become intense or disruptive, including profound vulval burning, intense itching, and tissue soreness. For these symptoms, the therapy offers symptomatic relief that helps ease the overall burden of these acute manifestations and supports the patient during difficult episodes by easing distress.

“The treatment helps address symptom clusters that may become intense or disruptive, supporting the patient during difficult episodes by easing distress.”

The combination product is relevant for supporting local coverage, treating both the internal infection and the external irritation. It is also relevant when supporting the management of the sexual partner to support the management of re-infection episodes. Commonly managed conditions include vaginal candidiasis, candidal vaginitis, and the associated candidal vulvitis.


Quick Fact: Relief for Intense Localized Discomfort


Regulatory References

  1. NIH MedlinePlus overview of Clotrimazole Vaginal

Eligibility and Restrictions for Use

Eligibility and Contraindications

Official regulatory documents define the eligibility for Clotrimazole vaginal and topical preparations. The medicine is absolutely contraindicated for patients with a known hypersensitivity to Clotrimazole or any other Imidazole antifungal agent. Exclusion also applies if there is an allergy to specific non-active ingredients.

The medicine is primarily intended for adult women (16 to 60 years of age) with uncomplicated candidiasis. Use is not recommended for self-treatment in individuals under 16 or over 60; these age groups must seek medical advice.

Populations Requiring Consultation

Patients are not eligible for self-treatment if they exhibit severe symptoms (e.g., fever, ulcers, abnormal bleeding, or lower abdominal pain) or have experienced more than two infections in the last six months.

  • Pregnancy and Lactation: Use during pregnancy is restricted, especially in the first trimester, and must proceed only under the supervision of a doctor or midwife. Use during lactation also requires medical oversight.
  • Contraceptive Restriction: Individuals relying on latex contraceptives (condoms, diaphragms) must use alternative barrier methods for at least five days after treatment, as the product may compromise the integrity of the latex material.

What should I know about interactions with other medicines?

The official regulatory profile for Clotrimazole (Canesten Thrush) documents specific interaction patterns, primarily due to minimal systemic absorption and local product compatibility constraints.

Systemic Pharmacokinetic Interactions

A pharmacokinetic interaction is formally documented, driven by the medicine's potential to inhibit the CYP3A4 enzyme. Although systemic absorption is low, this effect may cause an increase in the plasma concentrations of certain co-administered medicinal products. This is specifically relevant for the immunosuppressants oral Tacrolimus and oral Sirolimus. When these agents are co-administered, therapeutic drug monitoring and dose adjustment procedures are officially required to manage the change in drug exposure.

Local Constraints and Pharmacodynamic Antagonism

Regulatory documents define strict constraints for co-administration. The use of tampons, intravaginal douches, spermicides, or other vaginal products is officially restricted during the period of therapy.

A key Product-Material Integrity Interaction exists with latex contraceptives, such as condoms and diaphragms, as the components can compromise the latex material. This requires users to employ alternative methods of contraception for a period of at least five days after the product has been used.

A Pharmacodynamic Interaction is also noted with other antifungal agents, specifically Amphotericin B and Nystatin, where co-administration may result in decreased therapeutic effectiveness. No specific interactions with food, alcohol, or herbal products are explicitly documented for the vaginal and topical formulations.

Mechanism of Action

Targeting Fungal Cell Membrane Synthesis

Clotrimazole exerts its mechanism by inhibiting a vital fungal enzyme called Lanosterol 14-alpha-demethylase (CYP51). This mechanism acts within the fungal cell's ergosterol biosynthesis pathway, inhibiting the synthesis of ergosterol, which is an essential sterol component of the fungal cell membrane.


Mechanistic Cascade Leading to Cellular Lysis

By preventing ergosterol formation, the drug forces the fungal cell to accumulate toxic intermediary substances, severely compromising the membrane's structure and function. This damage increases the cell membrane's permeability, causing essential internal components to leak out, which results in the cessation of fungal growth (fungistasis) and subsequent fungal cell lysis (fungicidal action).


Biological Limitations of the Mechanism

The primary limitation of this mechanism involves the potential for acquired fungal resistance. The fungus can evolve by mutating the target enzyme or by developing efflux pumps that actively expel the Clotrimazole molecule, thus limiting its concentration required to disrupt the ergosterol pathway and complete the destructive cascade.

Dosage and Administration Information

The official use of Canesten Thrush, which contains the active ingredient Clotrimazole, is strictly defined by guidelines for local administration via the intravaginal (pessary) and topical/dermal (external cream) routes. These forms are typically used concurrently, following specific regimens that structure the total course of treatment. The intravaginal dose is always administered at night to facilitate complete dissolution and retention of the medicine in the vagina.

Official dosing for the vaginal tablet is non-adjustable and fixed to short-term courses. Standard adult regimens include a single application of the 500 mg tablet or multi-day use, such as one 200 mg tablet inserted daily for three consecutive days. The external cream is applied thinly to the vulva and surrounding skin two to three times per day, with treatment typically continued for up to seven days. Use of the medicine in children under 12 years requires medical supervision.

Procedural constraints are key to proper use. Treatment is advised against during menstruation to prevent the dose from being washed out. Patients are explicitly instructed to avoid the concurrent use of other intravaginal products, including tampons, douches, and spermicides. Furthermore, labeling notes that Clotrimazole may compromise the integrity of latex barrier contraceptives, and alternative methods must be used for at least five days after the course is complete.

Recent Clinical Evidence

Recent Clinical Evidence: Clotrimazole for Vulvovaginal Candidiasis

Clotrimazole, the active agent in Canesten Thrush products, is an azole antifungal widely evaluated for the treatment of vulvovaginal candidiasis (VVC), commonly known as thrush.

Efficacy and Dosing Regimens

Clinical data from randomized controlled studies on women with uncomplicated VVC suggest that single intravaginal doses of clotrimazole (typically 500 mg vaginal tablets) can provide high mycological and clinical cure rates. Research comparing clotrimazole to oral azole antifungals has reported that the efficacy of the single-dose topical treatment is comparable for uncomplicated infections.

Studies also explored the effectiveness of prolonged treatment regimens (e.g., 7–14 days) in severe, recurrent, or complicated cases, as well as in symptomatic pregnant women. Research examining different clotrimazole strengths and durations, including 3-day and 7-day courses, suggests that various short-term regimens may be used depending on the product formulation and severity of the infection.

Clinical Finding Primary Research Focus
Efficacy of single-dose clotrimazole Compared to oral azoles in uncomplicated VVC
Combined vulva/vaginal treatment Associated with greater reported reduction in external symptoms

Safety Profile and Combination Use

Topical clotrimazole demonstrates poor systemic absorption following intravaginal administration, which may contribute to its favourable systemic tolerability profile. Reported side effects are typically local in nature. These may include a temporary sensation of burning, irritation, or itching at the application site, which is documented to occur in a minority of patients.

Research has explored combination therapy, specifically the use of an intravaginal preparation alongside an external cream for vulvar symptoms. These studies reported that the combined approach was associated with a greater reduction in external symptoms, such as burning and itching, compared to treatment with the vaginal preparation alone.

Key Studies & References Management of Vulvovaginal Candidiasis: Practice Bulletin No. 215 (ACOG)

Frequently Asked Questions (FAQ)

Common questions about Canesten Thrush (FAQ)


Q: Does Canesten Thrush have different types of products, like creams or tablets?

Products containing Clotrimazole, the active ingredient in Canesten Thrush, are available in multiple dosage forms. These typically include preparations for internal use, such as vaginal tablets (pessaries), and external preparations, such as creams, designed for local application.


Q: Is Canesten Thrush the same as other treatments for thrush?

The active ingredient in this product is recognized in clinical practice for its use in treating thrush. Canesten Thrush products contain the active ingredient Clotrimazole, which belongs to the azole class of antifungal medicines. Regulatory texts also indicate a potential for reduced effect if it is used concurrently with certain other antifungal agents.


Q: How quickly should Canesten Thrush start to work after I use it?

Official information indicates that symptoms of the infection, such as itching or soreness, should generally begin to show improvement within a few days of starting the treatment course. If expected improvement does not occur within the timeframe noted in the product information, seeking guidance from a healthcare professional may be appropriate.


Q: What is the typical duration of treatment for Canesten Thrush?

The official duration of treatment varies depending on the specific product formulation being used. Regulatory regimens include options for single-day use or multi-day courses, which can range from three to seven consecutive days.


Q: What happens if I stop using Canesten Thrush before the full course is finished?

Regulatory guidance indicates that using the medicine for the full prescribed time is intended to help ensure the infection is completely cleared. Stopping use prematurely may lead to the infection not being fully resolved, which could result in symptoms returning.


Q: Are there any common reasons why Canesten Thrush might not work for someone?

If expected improvement does not occur, or if the infection recurs often, official regulatory information suggests that consulting a healthcare professional is appropriate to review the diagnosis or treatment.


Q: Is it safe to use Canesten Thrush while I have my period?

Regulatory administration instructions indicate that treatment with internal products is typically advised against during the menstrual period, as this may lead to the dose being washed out, potentially reducing the intended effect. Users are often instructed to finish the course before menstruation.


Q: Do you need to treat a partner even if they don't have symptoms?

For the prevention of re-infection, official documents note that the external cream can be applied to a sexual partner's penis. General health guidance suggests that asymptomatic partners often do not need treatment. Decisions regarding partner treatment are best made in consultation with a healthcare professional.


Q: Can Canesten Thrush products damage or interact with condoms or diaphragms?

Yes, regulatory warnings state that laboratory tests have suggested the components in the product may cause damage to latex barrier contraceptives, such as condoms and diaphragms. This may reduce their effectiveness in preventing pregnancy or sexually transmitted infections.


Q: What happens if a dose of Canesten Thrush is missed?

The official product information typically advises that if a dose is missed, it may be applied as soon as it is remembered. The individual should then resume the scheduled treatment plan.


Q: Can Canesten Thrush be used if someone is pregnant?

Official regulatory labeling indicates that use during pregnancy is possible due to low systemic absorption, but it requires oversight by a physician or midwife. This information should be reviewed with a healthcare professional.


Q: Is it true that Canesten Thrush is available in different strengths?

Yes, the active ingredient, Clotrimazole, is available in varying dosage forms and strengths. This includes different percentage concentrations for external creams and different milligram doses for internal vaginal tablets (pessaries). The specific dose and regimen used will be determined by the specific product purchased.


Q: Are there any long-term side effects associated with using Canesten Thrush?

Adverse reactions documented in official regulatory documents are primarily local in nature, such as irritation or burning at the application site, and these typically resolve after the product is stopped. Serious systemic reactions are documented as rare, or with frequency not known, based on ongoing post-marketing surveillance.


Q: Can frequent use of Canesten Thrush be harmful?

Regulatory guidance indicates that if an individual experiences frequent vaginal infections, typically more than twice in six months, it may be appropriate to consult a healthcare professional to identify any underlying factors or alternative treatments.


Q: Is there a specific age limit for using Canesten Thrush products?

Official information notes that self-treatment is not recommended for individuals under 16 or over 60 years of age, who are typically advised to seek medical guidance before use. Use in children under 12 years of age requires medical supervision.


Q: Why do some Canesten Thrush treatments come with an external cream and an internal component?

Treatments often combine both internal and external components because clinical research suggests that using the internal preparation alongside the external cream is associated with a greater reported reduction in external symptoms, such as burning and itching, compared to internal treatment alone.


Q: Does alcohol consumption affect the use of Canesten Thrush?

No specific interactions between the vaginal and topical formulations of the product and alcohol consumption are explicitly documented in the official regulatory information.


Q: Can I use Canesten Thrush if I am taking an oral contraceptive pill?

The medicine is noted in some sources to potentially interact with certain types of oral contraceptives, which may affect the level of the contraceptive's active ingredient. For individuals taking oral contraceptive pills, it is appropriate to discuss the specific situation with a healthcare professional for guidance.


Q: What is the purpose of the applicators provided with some internal treatments?

Applicators are provided with some internal treatments, such as vaginal creams or pessaries, to facilitate the deep intravaginal insertion of the medicine. This proper placement is consistent with the instructions provided for the effective administration of the internal treatments.


Q: What should be done if Canesten Thrush gets into the eyes?

Official warnings state that the products are not for ophthalmic use, meaning they should not be used in the eyes. Regulatory information confirms the product is not for use in the eyes and states that contact with the eyes should be avoided during use.


Q: Can Canesten Thrush be used for other types of skin irritation?

The external cream formulation is an antifungal medicine that is used to treat fungal skin infections like ringworm and athlete’s foot, in addition to the external vulval irritation associated with thrush.


Q: Is there a possibility of the infection returning after using Canesten Thrush?

Recurrence is possible. Regulatory guidance notes that if the infection returns in less than two months, consulting a healthcare professional may be appropriate, as recurrence may indicate an underlying factor requiring attention.


Q: What is the main benefit of the combination pack compared to the internal treatment alone?

Research indicates that using a combination pack, which includes both internal and external treatments, is associated with a greater reported reduction in external symptoms like burning and itching, providing more comprehensive relief than the internal treatment alone.


Q: Does using scented soaps or products affect how Canesten Thrush works?

While no direct interaction is documented, general hygienic guidance from health authorities for vaginal infections often includes avoiding irritants like douches and scented feminine hygiene products. These practices may be associated with irritation or conditions that contribute to fungal overgrowth.


Q: Can people with diabetes use Canesten Thrush safely?

Official regulatory information indicates that individuals with underlying conditions that increase the risk of thrush, such as diabetes, are typically advised to consult a healthcare professional prior to using the product.


Q: How is the safety of Canesten Thrush monitored by regulatory bodies?

The safety of the medicine is continuously monitored by regulatory bodies through systems like pharmacovigilance. This involves documenting and assessing reports of adverse reactions that arise spontaneously after the product is marketed.


Q: How does the cream or pessary consistency change once it's inside the body?

The intravaginal dose, such as a pessary, is typically administered at night. This timing is intended to facilitate the complete dissolution and retention of the medicine within the vagina to allow the active ingredient to work locally.


Q: Are there specific instructions for what to wear while using the external cream?

Although the product label may not specify clothing, general hygienic advice from health authorities for vaginal infections often includes wearing freshly washed cotton underwear and loose-fitting pants, which may be consistent with general hygienic practices recommended to support recovery from the infection.


Q: How long does the active ingredient stay in the system after the treatment ends?

Official pharmacokinetic data indicates that systemic absorption of the active ingredient is negligible following intravaginal and topical use. Therefore, only very small amounts enter the bloodstream and are quickly eliminated from the body.


Q: Is it necessary to avoid sexual activity while using Canesten Thrush?

General health authority guidance often suggests avoiding sexual activity until the course of treatment is finished and symptoms have fully resolved. This is separate from the documented interaction with latex contraceptives.

How should Canesten Thrush be stored and disposed of?

Canesten Thrush products, which contain the active ingredient clotrimazole, should be stored properly to maintain their efficacy.

Storage Guidelines

Product Form Temperature Limit
Cream, Vaginal Cream, and Combi Packs Do not store above 25°C (77°F)
Vaginal Pessaries (Tablets) Store below 25°C or 30°C, depending on specific formulation (check package)

All forms must be kept in their original packaging and strictly out of the sight and reach of children. Do not use the medicine after the expiry date printed on the carton or tube.

Disposal Instructions

To protect the environment, unused or expired medication, including Canesten Thrush products and used applicators, should not be disposed of via wastewater, flushed down the toilet, or placed in general household waste. Return any no-longer-required medicine to your pharmacist for safe and environmentally responsible disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Canesten Thrush found in:

A-Z Index: